Stay updated on Study of ZN-c3 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Study of ZN-c3 in Solid Tumors Clinical Trial page.

Latest updates to the Study of ZN-c3 in Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference2%
- Check38 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
- Check53 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check60 days agoChange DetectedThe website has updated the type of intervention to 'Verified 2023-01 by K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc' with a new status of 'Recruiting' and has revised to version 2.14.0, while the previous version 2.13.3 has been removed.SummaryDifference1%
- Check67 days agoChange DetectedThe website has added a section labeled 'Unknown status' while removing the 'Recruiting' section.SummaryDifference0.1%
Stay in the know with updates to Study of ZN-c3 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study of ZN-c3 in Solid Tumors Clinical Trial page.